Agency Information Collection Activities: Proposed Collection; Comment Request, 5262-5264 [2018-02289]
Download as PDF
<![CDATA[
5262
Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices
NOTICE OF TERMINATION OF RECEIVERSHIPS—Continued
Receivership name
City
10301 ................
First Suburban National
Bank.
Peoples State Bank ...........
Habersham Bank ...............
Community Central Bank ...
All American Bank ..............
Putnam State Bank ............
Citizens First National Bank
Texas Community Bank,
National Association.
Premier Bank .....................
Maywood ............................................................................................
IL
2/1/2018
Hamtramck .........................................................................................
Clarksville ...........................................................................................
Mount Clemens ..................................................................................
Des Plaines ........................................................................................
Palatka ...............................................................................................
Princeton ............................................................................................
The Woodlands ..................................................................................
MI
GA
MI
IL
FL
IL
TX
2/1/2018
2/1/2018
2/1/2018
2/1/2018
2/1/2018
2/1/2018
2/1/2018
Denver ................................................................................................
CO
2/1/2018
10341
10345
10359
10409
10445
10464
10491
................
................
................
................
................
................
................
10515 ................
The Receiver has further irrevocably
authorized and appointed FDICCorporate as its attorney-in-fact to
execute and file any and all documents
that may be required to be executed by
the Receiver which FDIC-Corporate, in
its sole discretion, deems necessary,
including but not limited to releases,
discharges, satisfactions, endorsements,
assignments, and deeds. Effective on the
termination dates listed above, the
Receiverships have been terminated, the
Receiver has been discharged, and the
Receiverships have ceased to exist as
legal entities.
Dated: February 1, 2018.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2018–02286 Filed 2–5–18; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project
‘‘Expanding the Comprehensive Unitbased Safety Program (CUSP) to Reduce
Central Line-Associated Blood Stream
Infections (CLABSI) and CatheterAssociated Urinary Tract Infections
(CAUTI) in Intensive Care Units (ICU)
with Persistently Elevated Infection
Rates.’’
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:48 Feb 05, 2018
Jkt 244001
This proposed information collection
was previously published in the Federal
Register on July 28, 2017, and allowed
60 days for public comment. AHRQ did
not receive any substantive public
comments. In response to internal
project team feedback, the proposed
data collection has been modified in
order to increase efficiency and decrease
respondent burden. Modifications
include consolidation of two data
collection tools (the Team Checkup Tool
and the ICU Assessment) into one ICU
Assessment and decreasing the
frequency of administration. The
modifications also now require broad
administration of the ICU Action Plan,
which previously was administered
only to those sites that had a site visit.
The purpose of this notice is to allow an
additional 30 days for public comment.
DATES: Comments on this notice must be
received by March 8, 2018.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
email at OIRA_submission@
omb.eop.gov (attention: AHRQ’s desk
officer).
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Expanding the Comprehensive Unitbased Safety Program (CUSP) to reduce
Central Line-Associated Blood Stream
Infections (CLABSI) and CatheterAssociated Urinary Tract Infections
(CAUTI) in Intensive Care Units (ICU)
with persistently elevated infection
rates.
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
Healthcare-associated infections, or
HAIs, are a highly significant cause of
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
State
Termination
date
Fund
illness and death for patients in the U.S.
health care system. At any given time,
HAIs affect one out of every 25 hospital
inpatients. More than a million of these
infections occur across the health care
system every year, leading to significant
patient harm and the annual loss of tens
of thousands of lives, and costing
billions of dollars each year. Some of
the most prevalent HAIs include:
Surgical site infections (SSIs), catheterassociated urinary tract infections,
central-line associated blood stream
infections, and ventilator-associated
pneumonia (VAP). It is estimated that
CAUTIs affect approximately 250,000
hospital patients per year, and
approximately 40,000 CLABSI cases
occur annually with a mortality rate
from 12 to 25 percent.
From 2008–2012, AHRQ supported
the National Implementation of the
Comprehensive Unit-Based Safety
Program (CUSP) to reduce Central LineAssociated Blood Stream Infections
(CLABSI) under an ACTION contract
with the Health Research and
Educational Trust (HRET), in
partnership with Johns Hopkins
University and the Michigan Hospital
Association. From 2011–2015, AHRQ
expanded its CUSP efforts to include the
national implementation of CUSP for
CAUTI in hospitals across the United
States. This effort was carried out under
an ACTION II contract with HRET, in
partnership with Johns Hopkins
University and the Michigan Hospital
Association.
As part of the Department of Health
and Human Services National Action
Plan to Prevent Healthcare-Associated
Infections, AHRQ has supported the
implementation and adoption of the
CUSP for CLABSI and CUSP for CAUTI,
and is applying the principles and
concepts that have been learned from
these HAI reduction efforts to ICUs with
persistently elevated infection rates.
E:\FR\FM\06FEN1.SGM
06FEN1
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices
Results of Implementation of CUSP for
CLABSI and CAUTI
The nationwide CUSP for CLABSI
project was implemented with teams at
more than 1,100 adult ICUs in 44 states
over a 4-year period. ICUs participating
in this project reduced the rate of
CLABSIs nationally from 1.915
infections per 1,000 central line days to
1.133 infections per 1,000 line days, an
overall reduction of 41 percent.
However, not all ICUs performed
equally well.
The CUSP for CAUTI project
implemented CUSP in nine cohorts,
representing over 1,600 hospital units in
over 1,200 hospitals located across 40
states, the District of Columbia, and
Puerto Rico. Inpatient CAUTI rates in
non-ICUs were decreased by 30%.
However, CAUTI rates in ICUs were not
reduced significantly.
In other words, while the overall
results of the implementation of CUSP
for CLABSI and CUSP for CAUTI have
shown remarkable progress, not all ICUs
in the projects have achieved the
intended rate reductions, nor have all
ICUs participated in the two projects.
Moreover, a significant number of
institutions and ICUs continue to have
persistently elevated infection rates.
There are institutions that have varying
rates of infections within the same
institution, indicating that infection
control is often a unit-based issue.
In sum, despite the significant overall
reductions in CLABSI and CAUTI rates
that have been achieved in these two
projects, there is evidence that ICUs
have generally faced challenges in
reducing CAUTI rates, and that many
hospitals still are not where they should
be in reducing CLABSI rates. Modified
approaches and strategies for the CUSP
intervention need to be developed and
implemented to reach ICUs with
persistently elevated CLABSI and
CAUTI rates and help them succeed in
preventing these infections. To address
this need, AHRQ will launch this
project aimed at spreading nationally
implementation of an adaptation of
CUSP for CLABSI and CAUTI for ICUs
with persistently elevated rates,
optimizing the approach to maximize
effectiveness and further preventing
these infections throughout the United
States.
This project has the following goals:
• Reduce CLABSI and CAUTI in ICUs
with persistently elevated rates.
VerDate Sep<11>2014
19:02 Feb 05, 2018
Jkt 244001
• Revise and augment current CUSP
training resources and materials for
CUSP for CLABSI and CAUTI in ICUs
with persistently elevated rates. The
resulting toolkit will be intended for use
in ICUs whose infection rates for either
or both of these HAIs are persistently
elevated compared to other ICUs.
• Recruit 450–600 ICUs nationally
with persistently elevated rates to
demonstrate the utility of applying a
modified CUSP for CLABSI and CUSP
for CAUTI during the performance
period to reduce rates of CLABSI and
CAUTI in these ICUs.
• Assess the adoption of the modified
CUSP for CLABSI and CAUTI and
evaluate the effectiveness of the
intervention in the participating ICUs.
This study is being conducted by
AHRQ through its contractor HRET.
Expanding the Comprehensive Unitbased Safety Program (CUSP) to reduce
Central Line-Associated Blood Stream
Infections (CLABSI) and CatheterAssociated Urinary Tract Infections
(CAUTI) in Intensive Care Units (ICU)
with persistently elevated infection rates
is being undertaken pursuant to AHRQ’s
statutory authority to conduct and
support research on health care and on
systems for the delivery of such care,
including activities with respect to the
quality, effectiveness, efficiency,
appropriateness and value of health care
services and with respect to quality
measurement and improvement.
42 U.S.C. 299a(a)(1) and (2).
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
(1) ICU Assessment Tool: The ICU
assessment tool will be completed by
the unit project team leader in
collaboration with individuals with
strong knowledge of current clinical and
safety practices in the ICU, such as the
ICU manager, infection preventionist,
quality leader, clinical educator, or
clinical nurse specialist at the start of
the cohort. The purpose of this
assessment is to understand current HAI
prevention practices, policies, and
procedures to tailor the educational
program to meet the needs of the ICU.
The assessment also addresses unit
safety culture and CUSP safety practices
with questions from the AHRQ Team
Checkup Tool. Results from this
assessment will be one of the key tools
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
5263
participating ICUs will use in
developing their action plans.
(2) Action plans: After completing
and receiving the results of their ICU
assessment, the unit team members
(such as the ICU manager, quality
leader, clinical educator, or clinical
nurse specialist) will complete an action
plan. The unit team will be encouraged
to use other data sources (e.g., CAUTI
and/or CLABSI rates from the National
Healthcare Safety Network [NHSN],
culture assessments) to identify gaps
that they plan to address through
participation in the project. ICU teams,
with coaching support from their state
lead, clinical mentor, and subject matter
experts, will determine which
educational materials will help the ICU
achieve its action plan goals. ICU teams,
state leads, and clinical mentors will
refer to these action plans to monitor
progress in achieving the goals.
(3) Site Visits: State leads and clinical
mentors will coordinate state-level, inperson site visits for 200 participating
hospital units over the entire project.
Site visits are an opportunity for state
leads and clinical mentors to meet with
ICU teams and their leadership to
strengthen relationships, engage in open
discussion about infection prevention,
and discuss the unit’s progress in
implementing its action plan. The Site
Visit Guidance document helps state
leads identify ICUs to visit, plan
agendas, schedule visits, prepare for
visits, and plan discussion questions.
This data collection effort will be part
of a comprehensive evaluation strategy
to assess the adoption of the Expansion
of the Comprehensive Unit-Based Safety
Program (CUSP) for CLABSI and CAUTI
in ICUs with persistently elevated rates;
measure the effectiveness of the
interventions in the participating units;
and evaluate the characteristics of teams
that are associated with successful
implementation and improvements in
outcomes.
The evaluation of this data collection
is largely foundational in nature as
AHRQ seeks information on the
implementation and effectiveness of the
CUSP for CLABSI and CAUTI in ICUs
with persistently elevated rates. The
evaluation of the tools above will utilize
a pre-post design, comparing practices,
policies and procedures before and after
participating in the program.
Estimated Annual Respondent Burden
E:\FR\FM\06FEN1.SGM
06FEN1
5264
Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Hours per
response
Total burden
hours
ICU Assessment ..............................................................................................
ICU Action Plan ...............................................................................................
Site Visits .........................................................................................................
150
150
100
1
1
1
1.25
2
4
187.5
300
400
Total ..........................................................................................................
400
N/A
N/A
887.5
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
ICU Assessment Tool ......................................................................................
ICU Action Plan ...............................................................................................
Site Visits .........................................................................................................
150
150
100
........................
........................
........................
187.5
300
100
200
50
50
a $52.58
d 98.83
$9,858.75
15,774
2,787
6,940
2,629
4,941.50
400
887.5
N/A
42,930.25
Total ..........................................................................................................
Total burden
hours
Average
hourly wage
rate *
Form name
a 52.58
b 27.87
c 34.70
a 52.58
Total cost
burden
a Based
on the mean wages for 11–9111 Medical and Health Services Managers.
on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
c Based on the mean wages for 29–1141 Registered Nurse.
d Based on the mean wages for 29–1069 Physicians and Surgeons, All other.
National Compensation Survey: Occupational wages in the United States May 2016 ‘‘U.S. Department of Labor, Bureau of Labor Statistics:’’
https://www.bls.gov/oes/current/oes_stru.htm.
b Based
daltland on DSKBBV9HB2PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ’s health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018–02289 Filed 2–5–18; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
19:02 Feb 05, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public, limited only by room seating.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is February 14,
2018. Written comments must include
full name, address, organizational
affiliation, email address of the speaker,
topic being addressed and specific
comments. Written comments must not
exceed one single-spaced typed page
with 1-inch margins containing all items
above. Only those written comments
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
received 10 business days in advance of
the meeting will be included in the
official record of the meeting. Public
comments made in attendance must be
no longer than 3 minutes and the person
giving comments must attend the public
comment session at the start time listed
on the agenda. Time for public
comments may start before the time
indicated on the agenda. The meeting
will be webcast live via the World Wide
Web; for instructions and more
information on ACIP please visit the
ACIP website: https://www.cdc.gov/
vaccines/acip/.
DATES: The meeting will be held on
February 21, 2018, 8:00 a.m. to 5:45
p.m., EDT, and February 22, 2018, 8:00
a.m. to 12:30 p.m. EDT.
ADDRESSES: CDC, 1600 Clifton Road,
NE, Tom Harkin Global
Communications Center, Kent ‘Oz’
Nelson Auditorium, Atlanta, Georgia
30329.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD.
Email ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)]
[Notices]
[Pages 5262-5264]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02289]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project ``Expanding the Comprehensive Unit-based Safety Program (CUSP)
to Reduce Central Line-Associated Blood Stream Infections (CLABSI) and
Catheter-Associated Urinary Tract Infections (CAUTI) in Intensive Care
Units (ICU) with Persistently Elevated Infection Rates.''
This proposed information collection was previously published in
the Federal Register on July 28, 2017, and allowed 60 days for public
comment. AHRQ did not receive any substantive public comments. In
response to internal project team feedback, the proposed data
collection has been modified in order to increase efficiency and
decrease respondent burden. Modifications include consolidation of two
data collection tools (the Team Checkup Tool and the ICU Assessment)
into one ICU Assessment and decreasing the frequency of administration.
The modifications also now require broad administration of the ICU
Action Plan, which previously was administered only to those sites that
had a site visit. The purpose of this notice is to allow an additional
30 days for public comment.
DATES: Comments on this notice must be received by March 8, 2018.
ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by
email at [email protected] (attention: AHRQ's desk officer).
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
[email protected].
SUPPLEMENTARY INFORMATION:
Proposed Project
Expanding the Comprehensive Unit-based Safety Program (CUSP) to
reduce Central Line-Associated Blood Stream Infections (CLABSI) and
Catheter-Associated Urinary Tract Infections (CAUTI) in Intensive Care
Units (ICU) with persistently elevated infection rates.
In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3521, AHRQ invites the public to comment on this proposed information
collection.
Healthcare-associated infections, or HAIs, are a highly significant
cause of illness and death for patients in the U.S. health care system.
At any given time, HAIs affect one out of every 25 hospital inpatients.
More than a million of these infections occur across the health care
system every year, leading to significant patient harm and the annual
loss of tens of thousands of lives, and costing billions of dollars
each year. Some of the most prevalent HAIs include: Surgical site
infections (SSIs), catheter-associated urinary tract infections,
central-line associated blood stream infections, and ventilator-
associated pneumonia (VAP). It is estimated that CAUTIs affect
approximately 250,000 hospital patients per year, and approximately
40,000 CLABSI cases occur annually with a mortality rate from 12 to 25
percent.
From 2008-2012, AHRQ supported the National Implementation of the
Comprehensive Unit-Based Safety Program (CUSP) to reduce Central Line-
Associated Blood Stream Infections (CLABSI) under an ACTION contract
with the Health Research and Educational Trust (HRET), in partnership
with Johns Hopkins University and the Michigan Hospital Association.
From 2011-2015, AHRQ expanded its CUSP efforts to include the national
implementation of CUSP for CAUTI in hospitals across the United States.
This effort was carried out under an ACTION II contract with HRET, in
partnership with Johns Hopkins University and the Michigan Hospital
Association.
As part of the Department of Health and Human Services National
Action Plan to Prevent Healthcare-Associated Infections, AHRQ has
supported the implementation and adoption of the CUSP for CLABSI and
CUSP for CAUTI, and is applying the principles and concepts that have
been learned from these HAI reduction efforts to ICUs with persistently
elevated infection rates.
[[Page 5263]]
Results of Implementation of CUSP for CLABSI and CAUTI
The nationwide CUSP for CLABSI project was implemented with teams
at more than 1,100 adult ICUs in 44 states over a 4-year period. ICUs
participating in this project reduced the rate of CLABSIs nationally
from 1.915 infections per 1,000 central line days to 1.133 infections
per 1,000 line days, an overall reduction of 41 percent. However, not
all ICUs performed equally well.
The CUSP for CAUTI project implemented CUSP in nine cohorts,
representing over 1,600 hospital units in over 1,200 hospitals located
across 40 states, the District of Columbia, and Puerto Rico. Inpatient
CAUTI rates in non-ICUs were decreased by 30%. However, CAUTI rates in
ICUs were not reduced significantly.
In other words, while the overall results of the implementation of
CUSP for CLABSI and CUSP for CAUTI have shown remarkable progress, not
all ICUs in the projects have achieved the intended rate reductions,
nor have all ICUs participated in the two projects. Moreover, a
significant number of institutions and ICUs continue to have
persistently elevated infection rates. There are institutions that have
varying rates of infections within the same institution, indicating
that infection control is often a unit-based issue.
In sum, despite the significant overall reductions in CLABSI and
CAUTI rates that have been achieved in these two projects, there is
evidence that ICUs have generally faced challenges in reducing CAUTI
rates, and that many hospitals still are not where they should be in
reducing CLABSI rates. Modified approaches and strategies for the CUSP
intervention need to be developed and implemented to reach ICUs with
persistently elevated CLABSI and CAUTI rates and help them succeed in
preventing these infections. To address this need, AHRQ will launch
this project aimed at spreading nationally implementation of an
adaptation of CUSP for CLABSI and CAUTI for ICUs with persistently
elevated rates, optimizing the approach to maximize effectiveness and
further preventing these infections throughout the United States.
This project has the following goals:
Reduce CLABSI and CAUTI in ICUs with persistently elevated
rates.
Revise and augment current CUSP training resources and
materials for CUSP for CLABSI and CAUTI in ICUs with persistently
elevated rates. The resulting toolkit will be intended for use in ICUs
whose infection rates for either or both of these HAIs are persistently
elevated compared to other ICUs.
Recruit 450-600 ICUs nationally with persistently elevated
rates to demonstrate the utility of applying a modified CUSP for CLABSI
and CUSP for CAUTI during the performance period to reduce rates of
CLABSI and CAUTI in these ICUs.
Assess the adoption of the modified CUSP for CLABSI and
CAUTI and evaluate the effectiveness of the intervention in the
participating ICUs.
This study is being conducted by AHRQ through its contractor HRET.
Expanding the Comprehensive Unit-based Safety Program (CUSP) to reduce
Central Line-Associated Blood Stream Infections (CLABSI) and Catheter-
Associated Urinary Tract Infections (CAUTI) in Intensive Care Units
(ICU) with persistently elevated infection rates is being undertaken
pursuant to AHRQ's statutory authority to conduct and support research
on health care and on systems for the delivery of such care, including
activities with respect to the quality, effectiveness, efficiency,
appropriateness and value of health care services and with respect to
quality measurement and improvement. 42 U.S.C. 299a(a)(1) and (2).
Method of Collection
To achieve the goals of this project the following data collections
will be implemented:
(1) ICU Assessment Tool: The ICU assessment tool will be completed
by the unit project team leader in collaboration with individuals with
strong knowledge of current clinical and safety practices in the ICU,
such as the ICU manager, infection preventionist, quality leader,
clinical educator, or clinical nurse specialist at the start of the
cohort. The purpose of this assessment is to understand current HAI
prevention practices, policies, and procedures to tailor the
educational program to meet the needs of the ICU. The assessment also
addresses unit safety culture and CUSP safety practices with questions
from the AHRQ Team Checkup Tool. Results from this assessment will be
one of the key tools participating ICUs will use in developing their
action plans.
(2) Action plans: After completing and receiving the results of
their ICU assessment, the unit team members (such as the ICU manager,
quality leader, clinical educator, or clinical nurse specialist) will
complete an action plan. The unit team will be encouraged to use other
data sources (e.g., CAUTI and/or CLABSI rates from the National
Healthcare Safety Network [NHSN], culture assessments) to identify gaps
that they plan to address through participation in the project. ICU
teams, with coaching support from their state lead, clinical mentor,
and subject matter experts, will determine which educational materials
will help the ICU achieve its action plan goals. ICU teams, state
leads, and clinical mentors will refer to these action plans to monitor
progress in achieving the goals.
(3) Site Visits: State leads and clinical mentors will coordinate
state-level, in-person site visits for 200 participating hospital units
over the entire project. Site visits are an opportunity for state leads
and clinical mentors to meet with ICU teams and their leadership to
strengthen relationships, engage in open discussion about infection
prevention, and discuss the unit's progress in implementing its action
plan. The Site Visit Guidance document helps state leads identify ICUs
to visit, plan agendas, schedule visits, prepare for visits, and plan
discussion questions.
This data collection effort will be part of a comprehensive
evaluation strategy to assess the adoption of the Expansion of the
Comprehensive Unit-Based Safety Program (CUSP) for CLABSI and CAUTI in
ICUs with persistently elevated rates; measure the effectiveness of the
interventions in the participating units; and evaluate the
characteristics of teams that are associated with successful
implementation and improvements in outcomes.
The evaluation of this data collection is largely foundational in
nature as AHRQ seeks information on the implementation and
effectiveness of the CUSP for CLABSI and CAUTI in ICUs with
persistently elevated rates. The evaluation of the tools above will
utilize a pre-post design, comparing practices, policies and procedures
before and after participating in the program.
Estimated Annual Respondent Burden
[[Page 5264]]
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
ICU Assessment.................................. 150 1 1.25 187.5
ICU Action Plan................................. 150 1 2 300
Site Visits..................................... 100 1 4 400
---------------------------------------------------------------
Total....................................... 400 N/A N/A 887.5
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Average
Form name Number of Total burden hourly wage Total cost
respondents hours rate * burden
----------------------------------------------------------------------------------------------------------------
ICU Assessment Tool............................. 150 187.5 \a\ $52.58 $9,858.75
ICU Action Plan................................. 150 300 \a\ 52.58 15,774
Site Visits..................................... 100 100 \b\ 27.87 2,787
.............. 200 \c\ 34.70 6,940
.............. 50 \a\ 52.58 2,629
.............. 50 \d\ 98.83 4,941.50
---------------------------------------------------------------
Total....................................... 400 887.5 N/A 42,930.25
----------------------------------------------------------------------------------------------------------------
\a\ Based on the mean wages for 11-9111 Medical and Health Services Managers.
\b\ Based on the mean wages for 29-9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare
Practitioners and Technical Workers, All Other.
\c\ Based on the mean wages for 29-1141 Registered Nurse.
\d\ Based on the mean wages for 29-1069 Physicians and Surgeons, All other.
National Compensation Survey: Occupational wages in the United States May 2016 ``U.S. Department of Labor,
Bureau of Labor Statistics:'' https://www.bls.gov/oes/current/oes_stru.htm.
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ's health care research and
health care information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to enhance the quality, utility
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information upon the
respondents, including the use of automated collection techniques or
other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018-02289 Filed 2-5-18; 8:45 am]
BILLING CODE 4160-90-P
